Captrust Financial Advisors Ginkgo Bioworks Holdings, Inc. Transaction History

Captrust Financial Advisors

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$0.28 - $1.16 $839 - $3,476	2,997 Added 19.73%	18,190 $6,000
Q1 2024 May 15, 2024	SELL	$1.06 - $1.67 $64,980 - $102,374	-61,302 Reduced 80.14%	15,193 $17,000
Q4 2023 Feb 14, 2024	SELL	$1.26 - $1.79 $14,902 - $21,170	-11,827 Reduced 13.39%	76,495 $129,000
Q3 2023 Nov 14, 2023	BUY	$1.61 - $2.54 $12,654 - $19,964	7,860 Added 9.77%	88,322 $159,000
Q2 2023 Aug 14, 2023	BUY	$1.14 - $1.95 $37,843 - $64,732	33,196 Added 70.23%	80,462 $149,000
Q1 2023 May 15, 2023	BUY	$1.2 - $2.19 $56,719 - $103,512	47,266 New	47,266 $62,000
Q3 2022 Nov 16, 2022	BUY	$0.73 - $3.74 $15,063 - $77,174	20,635 Added 113.07%	38,885 $121,000
Q2 2022 Aug 23, 2022	SELL	$2.2 - $4.2 $43,518 - $83,080	-19,781 Reduced 52.01%	18,250 $43,000
Q2 2022 Aug 16, 2022	BUY	$2.2 - $4.2 $47,735 - $91,131	21,698 Added 132.85%	38,031 $91,000
Q1 2022 May 16, 2022	BUY	$2.83 - $8.69 $32,072 - $98,483	11,333 Added 226.66%	16,333 $66,000
Q4 2021 Feb 14, 2022	SELL	$8.31 - $14.92 $831 - $1,492	-100 Reduced 1.96%	5,000 $42,000
Q3 2021 Nov 16, 2021	BUY	$9.15 - $13.28 $46,665 - $67,728	5,100 New	5,100 $59,000

48.1M

Ticker DNA
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 1,287,779,968
Market Cap $10.2B
Description
Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agric...

Get notified when there are updates to the investment portfolio of Captrust Financial Advisors, based on Form 13F filings with the SEC.

Stay updated on Captrust Financial Advisors with notifications on news.